Correction to:EPHA2 feedback activation limits the response to PDEs inhibition in KRAS-dependent cancer cells  

作　　者：Yue-hong Chen Hao Lv Ning Shen Xiao-min Wang Shuai Tang Bing Xiong Jian Ding Mei-yu Geng Min Huang 

机构地区：[1]School of Life Science,Shanghai University,Shanghai 200444,China [2]Division of Antitumor Pharmacology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China [3]University of Chinese Academy of Sciences,Beijing 100049,China [4]Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China

出　　处：《Acta Pharmacologica Sinica》2024年第5期1093-1094,共2页中国药理学报（英文版）

摘　　要：Correction to:Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-019-0268-y,published online 17 July 2019 The authors are very sorry for two inadvertent mistakes in the figures:the images of immunoblot showing PDEδexpression and the corresponding GAPDH loading control in H1792 and H441 cells in Fig.2a were provided incorrectly.These errors were made due to our carelessness during the stage of figure preparation.

关 键 词：KRAS ACTIVATION preparation 

分 类 号：R730[医药卫生—肿瘤] G23[医药卫生—临床医学]